Navigation Links
Study Shows Metabolic Strategy of Stressed Cell

Major St. Jude Study of Changes in Gene Activity and Metabolic Enzymes Show How Cells Respond to a Sudden Decrease in the Levels of Coenzyme A, a Key Player in the Daily Biochemical Routines that Support Life

MEMPHIS, Tenn., March 23, 2007 /PRNewswire/ -- Investigators at St. Jude Children's Research Hospital have mapped out many of the dynamic genetic and biochemical changes that make up a cell's response to a shortage of a molecule called Coenzyme A (CoA), a key player in metabolism.

The results provide the most detailed look ever obtained of the complex metabolic changes in a cell triggered by a potentially fatal stress. CoA plays key roles in the cell's metabolism by participating in biochemical reactions in specific areas throughout the cell.

"The study provides the first detailed look at how the cell shifts genetic gears to respond to a significant change in its ability to carry on its daily metabolic chores," said Suzanne Jackowski, Ph.D., a member of the St. Jude Infectious Diseases department and the paper's senior author.

The St. Jude study is a significant contribution to the growing field of metabolomics -- the study of the molecules involved in metabolism, added Charles Rock, Ph.D., a member of the St. Jude Infectious Diseases department and co-author of the paper. Coupled with genetic studies of the cell, metabolomics is giving scientists a more detailed picture of how the body maintains its health in both normal environments and during times of stress, such as starvation or disease.

A report on this work appears in the March issue of "Chemistry and Biology."

The researchers studied the response to decreased CoA in a mouse model by blocking CoA production. Following the shutdown of CoA production, the cells quickly recycled CoA from other jobs so it could concentrate all its efforts on a single task: extracting life-supporting energy from nutrients in the mitocho
'"/>




Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Study Shows Metabolic Strategy Stressed Cell
(Date:7/29/2015)... , July 27, 2015 Research ... addition of the "Global Neurostimulation Devices Market ... The analysts forecast the global neurostimulation devices market ... the period 2014-2019. The report, Global ... on an in-depth market analysis with inputs from ...
(Date:7/29/2015)... , July 29, 2015 The Judicial Panel ... week about whether to centralize Inferior vena cava (IVC) ... IVC manufacturer, Cook Medical, have already been centralized by ... implanted in patients at risk for a pulmonary embolism. ... traveling to the lungs. Claims against Bard and Cook ...
(Date:7/29/2015)... , July 29, 2015  ViaCyte, Inc., a privately-held regenerative ... the treatment of diabetes in clinical trials, today announced the opening ... ONE, or S afety, T olerability, and E ... Diabetes.  The new site, which is the first in ... Hospitals in Edmonton , Alberta.  ...
Breaking Medicine Technology:Global Neurostimulation Devices Market 2015-2019 2IVC filter litigation continues; law firm provides free information to IVC filter patients 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4
... - Poster Presented at ASCO Annual Meeting ... CHICAGO, May 31 /PRNewswire-FirstCall/,-- Poniard Pharmaceuticals, Inc. ... on oncology, today presented preliminary safety and,efficacy ... trial of picoplatin in,combination with docetaxel and ...
... 3 Study Presented at ASCO -, COLLEGEVILLE, ... Wyeth (NYSE: WYE ), today announced results,of ... patients with relapsed,and/or refractory mantle cell lymphoma (MCL), ... (mammalian target of rapamycin) inhibitor,TORISEL(R) (temsirolimus) experienced a ...
Cached Medicine Technology:Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 2Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 3Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 4New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 2New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 3New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 4New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 5New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 6
(Date:7/29/2015)... ... July 29, 2015 , ... More than ... service providers of children living with autism will converge upon Penn State to ... , The National Autism Conference will be held Aug. 3-6 at the ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to The Spirits Business on ... directly responsible for stimulating and perpetuating alcohol use disorders. Humans have the same gene, ... the National academy of Sciences, and has given researchers inklings to explore Rsu1 in ...
(Date:7/29/2015)... ... 2015 , ... With a new community program in the ... Support Services and announced a new charity campaign to raise funds to support ... workshops and educational programs at no charge. Scott Campbell Agency initiates this ...
(Date:7/29/2015)... New York, NY (PRWEB) , ... July 29, 2015 , ... Wedding season is in ... wedding bells comes the extra pressure of looking good on the big day. Every bride ... pre-wedding prep to a new level. , According to a recent study ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... the Hackett Hemwall Foundation in March, Steven W. Meier M.D., a prominent orthopedic ... treatments to qualifying patients with demonstrated financial need. , “We are thrilled for ...
Breaking Medicine News(10 mins):Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2
... collaborative team of researchers spearheaded by Dennis Carson M.D., professor ... UCSD Cancer Center at the University of California, San Diego ... a toxic blue-green algae found in the South Pacific. ... paper that will be published online in Proceedings of the ...
... leader in radiology and medical image and information management,solutions, today announced it ... ended December 31, 2007, before the,market opens on Friday, February 29, 2008., ... -- Friday, ... -- Call begins promptly at 8:30 a.m. (Eastern Time), 7:30 a.m. ...
... Finding could lead to less controversial method of treating ... scientists say they,ve reprogrammed human skin cells into ones ... a breakthrough that could aid in treating many diseases ... the ability to become every cell type found in ...
... an Integral Part of MedCath,s Growth Plans, CHARLOTTE, ... and its physician partners today announced plans to double,the ... Antonio, Texas,creating a 120-bed acute care and heart hospital., ... of shelled,space into 60 inpatient beds, which will be ...
... of acute coronary events such as heart attack in adults ... Italy, researchers reported in Circulation: Journal of the American Heart ... the city for five years preceding a public smoking ban ... found an 11.2 percent reduction of acute coronary events in ...
... physicians specializing in geriatrics, internal or family medicine or ... with heart failure are at risk of dying, new ... to determine whether patients are within six months of ... decisions such as therapeutic approaches and referral for palliative ...
Cached Medicine News:Health News:UCSD research team identifies novel anticancer drug from the sea 2Health News:AMICAS Schedules Fourth Quarter and 2007 Year End Earnings Results Conference Call 2Health News:Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 2Health News:Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 3Health News:MedCath Plans 60-bed Expansion at TexSAn Heart Hospital 2Health News:MedCath Plans 60-bed Expansion at TexSAn Heart Hospital 3Health News:Acute coronary events decreased after public smoking ban in Italy 2Health News:Acute coronary events decreased after public smoking ban in Italy 3Health News:Doctors uncertain about approaches to care for heart failure patients, SLU study finds 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: